  |
Focus Diagnostics Laboratory Examination Kits: Class I Recall - Inaccurate Test Results
Including: Laboratory examination kits supplied with Simplexa Herpes Simplex Virus 1 & 2, and Simplexa Group A Strep Direct Amplification Discs
AUDIENCE: Risk Manager, Internal Medicine, Patient
ISSUE: Focus Diagnostics is recalling Simplexa Herpes Simplex Virus 1 & 2 Direct and Simplexa Group A Strep Direct kits containing the Direct Amplification Discs due to poor lamination between the sample reaction wells. This poor lamination may lead to leakage into adjacent wells causing cross-contamination between samples, which could yield false positive, false negative, or invalid test results. Inaccurate diagnostic test results may lead to improper patient treatment for HSV or GAS and may cause serious adverse health consequences, including death.
- Model Numbers: MOL2150, MOL1451, MOL1452, MOL2850, and MOL1455.
- Manufacturing Dates: July 30, 2015 to February 11, 2016
- Distribution Dates: September 16, 2015 to February 11, 2016
BACKGROUND: The Direct Amplification Discs are Simplexa kit components used in combination with a molecular testing system (thermal cycler or thermocycler) to detect the presence of herpes simplex virus (HSV) or Group A Streptococcus (GAS).
RECOMMENDATION: On February 10, 2016, Focus Diagnostics sent a Customer Correction Notice letter to customers letting them know extra discs would be provided free of charge until the issue was resolved. The letter also asked customers to:
- check their inventories for defective products
- only run full discs
- avoid running partially used discs
- discard discs even after a partial run
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
- Complete and submit the report Online: www.fda.gov/MedWatch/report
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Read the MedWatch safety alert, including a link to the Recall Notice, at:
You are encouraged to report all serious adverse events and product quality problems to FDA MedWatch at www.fda.gov/medwatch/report.htm
Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com.
This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).
| This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332) |  |
